Company / Return on Assets (ROA)
10x Genomics, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-4.2%
FY2025
5-year range
-26.4% / -4.2%
FY2021-FY2025
Trend
+79.0%
vs FY2024
Sector context
#107 of 158
Health Care
What the data says
At -4.2%, 10x Genomics, Inc.'s return on assets (roa) ranks #107 of 158 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -90.5% in FY2018 to -4.2% in FY2025.
Based on SEC 10-K filings.
-4.2% in FY2025 with a 5-year CAGR of +54.2%.
Improved from -26.4% to -4.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +11.9pp
- 5-Year Change
- +54.2pp
- 10-Year Change
- -
Sector benchmark
#107 of 158 in Health CareTop 68% of 158This company -4.2% Sector average -2.2%
▼
-90.6% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 79.0% year-over-year.
- Currently 2.0pp below the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.2% | +79.0% |
| FY2024 | -19.9% | +24.8% |
| FY2023 | -26.4% | -63.9% |
| FY2022 | -16.1% | -182.5% |
| FY2021 | -5.7% | +90.2% |
| FY2020 | -58.4% | -1031.8% |
| FY2019 | -5.2% | +94.3% |
| FY2018 | -90.5% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026